Cambridge Investment Research Advisors
THC icon

Cambridge Investment Research Advisors’s Tenet Healthcare THC Stock Holding History

Cambridge Investment Research Advisors’s Portfolio THC Stock Details THC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$600K Sell
3,207
-270
-8% -$49.6K ﹤0.01% 2788
2026
Q1 		$656K Sell
3,477
-2,337
-40% -$492K ﹤0.01% 2567
2025
Q4 		$1.16M Sell
5,814
-153
-3% -$30.9K ﹤0.01% 1987
2025
Q3 		$1.21M Buy
5,967
+3,552
+147% +$630K ﹤0.01% 1904
2025
Q2 		$425K Buy
2,415
+840
+53% +$126K ﹤0.01% 2686
2025
Q1 		$212K Buy
+1,575
New +$207K ﹤0.01% 3161
2024
Q4 		– Sell
-7,950
Closed -$1.32M – 3586
2024
Q3 		$1.32M Buy
7,950
+6,251
+368% +$945K ﹤0.01% 1649
2024
Q2 		$226K Buy
+1,699
New +$205K ﹤0.01% 2940
2022
Q2 		– Sell
-3,999
Closed -$344K – 3205
2022
Q1 		$344K Sell
3,999
-15,241
-79% -$1.25M ﹤0.01% 2430
2021
Q4 		$1.57M Sell
19,240
-70
-0.4% -$5.12K 0.01% 1289
2021
Q3 		$1.28M Hold
19,310
– – 0.01% 1353
2021
Q2 		$1.29M Buy
19,310
+1,306
+7% +$81K 0.01% 1359
2021
Q1 		$936K Buy
18,004
+1,270
+8% +$64.2K 0.01% 1469
2020
Q4 		$668K Buy
+16,734
New +$540K ﹤0.01% 1574
2019
Q2 		– Sell
-10,946
Closed -$316K – 2346
2019
Q1 		$316K Buy
+10,946
New +$270K ﹤0.01% 1774

Other funds holding THC

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
GCM
Glenview Capital Management New York $5.49B AUM 46.89% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

Cambridge Investment Research Advisors's THC Position: Q2 2026 in Review

Cambridge Investment Research Advisors reduced its Tenet Healthcare (THC) stake by 7.8% in Q2 2026, selling an estimated $49.6K and leaving 3,207 shares worth $600K. The position accounts for ﹤0.01% of the portfolio, ranked #2788.

Cambridge Investment Research Advisors first reported a position in THC in Q1 2019 and has held it in 15 quarters since. The position peaked at $1.57M in Q4 2021. 681 funds tracked by Wall St. Rank hold THC as of Q2 2026.

  • Cambridge Investment Research Advisors held 3,207 shares of Tenet Healthcare worth $600K as of Q2 2026.
  • Cambridge Investment Research Advisors sold 270 Tenet Healthcare shares in Q2 2026, an estimated $49.6K.
  • Tenet Healthcare made up ﹤0.01% of Cambridge Investment Research Advisors's portfolio in Q2 2026, its #2788 holding.
  • Cambridge Investment Research Advisors first reported a position in Tenet Healthcare in Q1 2019 and has held it in 15 quarters since.
  • Cambridge Investment Research Advisors's Tenet Healthcare position peaked at $1.57M in Q4 2021.
  • 681 funds tracked by Wall St. Rank held Tenet Healthcare as of Q2 2026.

Based on Cambridge Investment Research Advisors's 13F filing for Q2 2026, filed 27 Jul 2026.